Fierce Pharma

Pfizer CEO Albert Bourla on FDA official Vinay Prasad: 'We have a problem with the leadership of CBER'

One of the most powerful voices in the biopharma industry, Pfizer CEO Albert Bourla, Ph.D., has weighed in with sharp ...
BioSpace

FDA’s Circle of Trust Is Shrinking, Making Many Decisions Feel Like ‘Fiat’

FDA decisions lack majority consensus, experts agree, possibly leading to less nuanced verdicts on new drug applications.

Pfizer CEO flags issues with FDA's vaccine leadership

Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay Prasad.
STAT

FDA Commissioner Marty Makary defends rare disease drug rejections, Vinay Prasad

FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and one of his deputies, Vinay ...

FDA watchers warn of 'chaos' inside agency, as regulatory delays, staff hemorrhaging risk America's health

Scientific, political pressures colliding at FDA, delaying rare disease treatment for patients who have few or no options, experts said at CNBC Cures Summit.
Wall Street Journal

A Welcome FDA Walkback on a Flu Vaccine

Is the White House putting a leash on Food and Drug Administration vaccine chief Vinay Prasad? Americans can hope so after the agency on Wednesday walked back Dr. Prasad’s startling summary refusal ...

Pfizer CEO flags concerns with US FDA's vaccine leadership

By Mariam Sunny March 2 (Reuters) - Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay Prasad, in response to a ...